Let's Combinate - Pharma + Medical Devices with Subhi Saadeh
Let's Combinate - Pharma + Medical Devices with Subhi Saadeh
Subhi Saadeh
127 - BIG Risk Management Changes in QMSR, Risk Acceptability, Risk Policy & Explaining vs. Justifying Risk Decisions with Naveen Aggarwal
48 minutes Posted Mar 13, 2024 at 10:00 am.
Interpreting the QMSR and Its Implications
Impact of QMSR on Risk Management
Risk Management in Practice
Insights from FDA Inspections and Warning Letters
The Importance of Process-Based Approach
Deep Dive into Risk Policy and Risk Acceptability
Understanding the Framework of 14971
The Role of Quality Policy in Risk Management
Risk Control
Risk Acceptability in Risk Policy
Understanding Risk Matrix
Risk Control and Quality Policy
Understanding Risk Acceptability Charts
0:00
48:25
Download MP3
Show notes
On this episode I was joined by Naveen Aggarwal founder of Creative Analytic Solutions and host of "Let's talk risk".
In this episode, Naveen walks through the big changes to risk management with the QMSR, and risk beyond safety. The episode covers the confusion surrounding the mandatory nature of risk management in particular and we spend the second half of the episode talk about risk acceptability charts, risk & quality policy, explaining vs. justifying risk based decision making with regards to the traffic light charts that most companies use for risk acceptance.
Episode Chapters:
Naveen Agarwal PhD is an Engineer by training with nearly 20 years of professional experience in Product Development, Quality Systems and Data Analytics. As a result, he's developed a very broad and deep expertise in all of the core functions involved in the entire lifecycle of medical products. Naveen joins us from Creative Analytics Solutions where his mission is Helping Medical Companies Build Safe Products. Naveen is a PhD Polymer scientist turned QM consultant and expert.